Biogen Inc.
BIIB
$185.07
$1.050.57%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.29B | 1.61B | 1.53B | 1.48B | 1.63B |
| Total Depreciation and Amortization | 779.90M | 763.70M | 744.30M | 708.90M | 673.20M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.19B | 1.00B | 702.90M | 653.40M | 725.30M |
| Change in Net Operating Assets | -1.06B | -920.60M | -861.00M | -260.00M | -155.20M |
| Cash from Operations | 2.20B | 2.45B | 2.12B | 2.58B | 2.88B |
| Capital Expenditure | -153.80M | -149.20M | -138.00M | -144.90M | -153.70M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | -1.07B | -1.07B | -1.07B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.22B | -8.80M | -91.20M | 439.20M | 429.30M |
| Cash from Investing | -1.37B | -158.00M | -1.30B | -780.50M | -799.20M |
| Total Debt Issued | 1.73B | 1.73B | 1.73B | -- | -- |
| Total Debt Repaid | -2.03B | -1.75B | -1.75B | -250.00M | -650.00M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.00M | -140.10M | -16.80M | -16.90M | -33.50M |
| Cash from Financing | -301.90M | -157.00M | -33.40M | -266.90M | -683.50M |
| Foreign Exchange rate Adjustments | 101.90M | 25.00M | 70.60M | -10.30M | -67.70M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 633.50M | 2.16B | 849.90M | 1.52B | 1.33B |